Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function
Author(s) -
Atsushi Hiraoka,
Kojiro Michitaka,
Takashi Kumada,
Namiki Izumi,
Masumi Kadoya,
Norihiro Kokudo,
Shoji Kubo,
Yutaka Matsuyama,
Osamu Nakashima,
Michiie Sakamoto,
Tadatoshi Takayama,
Takashi Kokudo,
Kosuke Kashiwabara,
Masatoshi Kudo
Publication year - 2017
Publication title -
liver cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.916
H-Index - 34
eISSN - 2235-1795
pISSN - 1664-5553
DOI - 10.1159/000479984
Subject(s) - hepatocellular carcinoma , medicine , gastroenterology , grading (engineering) , bilirubin , liver function , cutoff , hepatic function , civil engineering , physics , quantum mechanics , engineering
Recently, albumin-bilirubin (ALBI) scoring/grading, consisting of only albumin and total bilirubin, has been proposed. We examined the efficacy of this grading system for determining hepatic function in patients with hepatocellular carcinoma (HCC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom